141 related articles for article (PubMed ID: 38674184)
1. Safety and Efficacy of Moderate-Intensity Stereotactic Body Radiation Therapy for Ultra-Central Lung Tumor.
Rim CH; Yoon WS; Park S
Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674184
[No Abstract] [Full Text] [Related]
2. A preliminary experience of moderate-intensity stereotactic body radiation therapy for ultra-central lung tumor.
Park S; Kim Y; Yoon WS; Rim CH
Int J Radiat Biol; 2019 Sep; 95(9):1287-1294. PubMed ID: 31145016
[No Abstract] [Full Text] [Related]
3. Outcomes and toxicity of stereotactic body radiation therapy for advanced stage ultra-central non-small cell lung cancer.
Cong Y; Sun B; Wang J; Meng X; Xuan L; Zhang J; Liu J; Shen G; Wu S
Thorac Cancer; 2019 Jul; 10(7):1567-1575. PubMed ID: 31187604
[TBL] [Abstract][Full Text] [Related]
4. Risk-adapted stereotactic body radiation therapy for central and ultra-central early-stage inoperable non-small cell lung cancer.
Meng MB; Wang HH; Zaorsky NG; Sun BS; Zhu L; Song YC; Li FT; Dong Y; Wang JS; Chen HM; Yu XY; Yuan ZY
Cancer Sci; 2019 Nov; 110(11):3553-3564. PubMed ID: 31464032
[TBL] [Abstract][Full Text] [Related]
5. Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation.
Repka MC; Aghdam N; Kataria SK; Campbell L; Suy S; Collins SP; Anderson E; Lischalk JW; Collins BT
Radiat Oncol; 2017 Oct; 12(1):162. PubMed ID: 29052514
[TBL] [Abstract][Full Text] [Related]
6. Ultra-central Thoracic Re-irradiation Using 10-fraction Stereotactic Body Radiotherapy for Recurrent Non-small-cell Lung Cancer Tumors: Preliminary Toxicity and Efficacy Outcomes.
Sood S; Ganju R; Shen X; Napel MT; Wang F
Clin Lung Cancer; 2021 May; 22(3):e301-e312. PubMed ID: 33132058
[TBL] [Abstract][Full Text] [Related]
7. Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree.
Haseltine JM; Rimner A; Gelblum DY; Modh A; Rosenzweig KE; Jackson A; Yorke ED; Wu AJ
Pract Radiat Oncol; 2016; 6(2):e27-33. PubMed ID: 26577006
[TBL] [Abstract][Full Text] [Related]
8. Is stereotactic body radiotherapy for ultra-central lung tumor a feasible option? A systemic review and meta-analysis.
Rim CH; Kim Y; Kim CY; Yoon WS; Yang DS
Int J Radiat Biol; 2019 Mar; 95(3):329-337. PubMed ID: 30676182
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic body radiotherapy for Ultra-Central lung Tumors: A systematic review and Meta-Analysis and International Stereotactic Radiosurgery Society practice guidelines.
Yan M; Louie AV; Kotecha R; Ashfaq Ahmed M; Zhang Z; Guckenberger M; Kim MS; Lo SS; Scorsetti M; Tree AC; Sahgal A; Slotman BJ
Lung Cancer; 2023 Aug; 182():107281. PubMed ID: 37393758
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiation therapy for re-irradiation of persistent or recurrent non-small cell lung cancer.
Trovo M; Minatel E; Durofil E; Polesel J; Avanzo M; Baresic T; Bearz A; Del Conte A; Franchin G; Gobitti C; Rumeileh IA; Trovo MG
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1114-9. PubMed ID: 24661664
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
[TBL] [Abstract][Full Text] [Related]
12. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus.
Song SY; Choi W; Shin SS; Lee SW; Ahn SD; Kim JH; Je HU; Park CI; Lee JS; Choi EK
Lung Cancer; 2009 Oct; 66(1):89-93. PubMed ID: 19168260
[TBL] [Abstract][Full Text] [Related]
13. Ultra-central lung tumors: safety and efficacy of protracted stereotactic body radiotherapy.
Lodeweges JE; van Rossum PSN; Bartels MMTJ; van Lindert ASR; Pomp J; Peters M; Verhoeff JJC
Acta Oncol; 2021 Aug; 60(8):1061-1068. PubMed ID: 34191670
[TBL] [Abstract][Full Text] [Related]
14. A Prospective Phase 2 Study Evaluating Safety and Efficacy of Combining Stereotactic Body Radiation Therapy With Heat-based Ablation for Centrally Located Lung Tumors.
Sandler KA; Abtin F; Suh R; Cook RR; Felix C; Lee JM; Garon EB; Wu J; Luterstein EM; Agazaryan N; Tenn SE; Lee C; Steinberg ML; Lee P
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):564-573. PubMed ID: 29893274
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of stereotactic body radiotherapy 60 Gy in 8 fractions when prioritizing organs at risk for central and ultracentral lung tumors.
Zhao Y; Khawandanh E; Thomas S; Zhang S; Dunne EM; Liu M; Schellenberg D
Radiat Oncol; 2020 Feb; 15(1):61. PubMed ID: 32106868
[TBL] [Abstract][Full Text] [Related]
16. Local control and toxicity in a large cohort of central lung tumors treated with stereotactic body radiation therapy.
Modh A; Rimner A; Williams E; Foster A; Shah M; Shi W; Zhang Z; Gelblum DY; Rosenzweig KE; Yorke ED; Jackson A; Wu AJ
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1168-76. PubMed ID: 25303891
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiotherapy for central lung tumors.
Rowe BP; Boffa DJ; Wilson LD; Kim AW; Detterbeck FC; Decker RH
J Thorac Oncol; 2012 Sep; 7(9):1394-9. PubMed ID: 22843088
[TBL] [Abstract][Full Text] [Related]
18. The safety and effectiveness of stereotactic body radiotherapy for central versus ultracentral lung tumors.
Chang JH; Poon I; Erler D; Zhang L; Cheung P
Radiother Oncol; 2018 Nov; 129(2):277-283. PubMed ID: 30049454
[TBL] [Abstract][Full Text] [Related]
19. Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer.
Zhao X; Zhu X; Fei J; Ren H; Cao Y; Ju X; Yuan Z; Zhang H
Radiat Oncol; 2018 Oct; 13(1):205. PubMed ID: 30348187
[TBL] [Abstract][Full Text] [Related]
20. Tumor Control and Toxicity after SBRT for Ultracentral, Central, and Paramediastinal Lung Tumors.
Nguyen KNB; Hause DJ; Novak J; Monjazeb AM; Daly ME
Pract Radiat Oncol; 2019 Mar; 9(2):e196-e202. PubMed ID: 30496842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
